Why Biomanufacturing Startups Struggle to Scale Pichia pastoris—and How to Overcome It
For biotech startups developing proteins, enzymes, or biologics, Pichia pastoris is often the preferred choice among scalable protein expression platforms. It offers high yield, cost efficiency, and genetic flexibility. Yet, moving from lab-scale experiments to full-scale production remains one of the most underestimated challenges for early-stage companies. Many startups encounter significant technical and financial setbacks […]
Why Biomanufacturing Startups Struggle to Scale Pichia pastoris—and How to Overcome It Read More »